This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Church, J. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Church, J. A.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Human Immunodeficiency Virus...
Chlamydial Infections
Chlamydia trachomatis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 112 No. 2 August 2003, pp. 491

EFFECTIVENESS OF COL-1492, A NONOXYNOL-9 VAGINAL GEL, ON HIV-1 TRANSMISSION IN FEMALE SEX WORKERS: A RANDOMISED, CONTROLLED TRIAL

Joseph A. Church, MD

Los Angeles, CA

Van Damme L, Ramjee G, Alary M, et al. Lancet. 2002;360:962–964


    Purpose of the Study.
 TOP
 Purpose of the Study.
 Methods.
 Results.
 Conclusions.
 Reviewer's Comments.
 
Nonoxynol-9, marketed as a spermicidal contraceptive, has in vitro anti-human immunodeficiency virus (HIV) activity. This study was designed to assess the effectiveness of COL-1492, a nonoxynol-9 vaginal gel, in the prevention of HIV infection in women with a high risk of HIV exposure.


    Methods.
 TOP
 Purpose of the Study.
 Methods.
 Results.
 Conclusions.
 Reviewer's Comments.
 
This was a randomized, placebo-controlled, fully masked phase II/III trial with COL-1492. Eight hundred ninety-two female sex workers in 4 developing countries were assigned to receive the nonoxynol-9 gel (449 women) or a placebo gel (443 women). The primary endpoint was incident HIV infection; secondary endpoints included Neisseria gonorrhoeae and Chlamydia trachomatis infections.


    Results.
 TOP
 Purpose of the Study.
 Methods.
 Results.
 Conclusions.
 Reviewer's Comments.
 
Thirty-two percent of the women reported using >3 applicators per working day. In these women, the risk of HIV infection in nonoxynol-9 users was almost twice that in placebo users. In the 68% of women who used the applicators less frequently, there was no difference in HIV infection incidence. There were no significant effects on nonoxynol-9 on N gonorrhoeae or C trachomatis infections.


    Conclusions.
 TOP
 Purpose of the Study.
 Methods.
 Results.
 Conclusions.
 Reviewer's Comments.
 
COL-1492, a nonoxynol-9 containing vaginal gel does not protect high-risk women from HIV infection. Further, multiple applications of nonoxynol-9 appear to enhance the risk of HIV infection likely by causing local toxic effects on the vaginal mucosa.


    Reviewer’s Comments.
 TOP
 Purpose of the Study.
 Methods.
 Results.
 Conclusions.
 Reviewer's Comments.
 
This report is consistent with other trials that demonstrated that nonoxynol-9 was not effective in preventing sexually transmitted diseases including HIV and that it might actually increase the risk for HIV transmission. Because of these findings, the World Health Organization has concluded that nonoxynol-9 should not be used or promoted for the prevention of HIV or sexually acquired infections. For sexually active adolescents, only abstinence and condoms should be recommended for the prevention of HIV or other sexually acquired infections.


PEDIATRICS (ISSN 1098-4275). ©2003 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Church, J. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Church, J. A.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Human Immunodeficiency Virus...
Chlamydial Infections
Chlamydia trachomatis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?